Proteon Therapeutics (PRTO) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts PRTO Hot Sheet
Join SI Premium – FREE
Proteon Therapeutics (NASDAQ: PRTO) reported Q3 EPS of ($0.33), in-line with the analyst estimate of ($0.33).
For earnings history and earnings-related data on Proteon Therapeutics (PRTO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alnylam Pharma (ALNY) reported Q3 result ; Offers Guidance
- Integer Holdings Corp (ITGR) Misses Q3 EPS by 35c
- Federal Signal (FSS) Tops Q3 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
